MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728): Difference between revisions

@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / Wikidata QID @@
+Q52211232
@@ Property / Wikidata QID: Q52211232 / rank @@
+Normal rank
@@ Property / cites work @@
+One-Sample Multiple Testing Procedure for Phase II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Bivariate Sequential Designs for Phase II Trials
@@ Property / cites work: Bivariate Sequential Designs for Phase II Trials / rank @@
+Normal rank
@@ Property / cites work @@
+Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity
+Normal rank
@@ Property / cites work @@
+Designs for Group Sequential Phase II Clinical Trials
+Normal rank
@@ Property / cites work @@
+A Bayesian Approach to the Design of Phase II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Practical Bayesian Guidelines for Phase IIB Clinical Trials
+Normal rank
@@ Property / full work available at URL @@
+https://doi.org/10.1081/bip-100101181
+Normal rank
@@ Property / OpenAlex ID @@
+W2074887877
@@ Property / OpenAlex ID: W2074887877 / rank @@
+Normal rank